SQUAWK/NEWS
Menu
Live News EQUITY L impact

bioAffinity 8-K filing

bioAffinity Technologies files 8-K with SEC, disclosing other events and financial statements.

BIAF

Filed: 2026-05-27 AccNo: 0001493152-26-025338 Size: 304 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits